BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3621797)

  • 1. Molecular basis of endocrine-responsive cancers.
    Wittliff JL
    Clin Physiol Biochem; 1987; 5(3-4):160-78. PubMed ID: 3621797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidimensional chromatographic separation of estrogen receptors.
    Raubenheimer J; van der Walt LA
    Biomed Chromatogr; 1989 Nov; 3(6):255-61. PubMed ID: 2620146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid receptors in breast cancer.
    Desombre ER
    Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of ovarian hormones with normal endometrium and endometrial adenocarcinoma.
    Gurpide E; Holinka CF; Fleming H; Fridman O; Deligdisch L; Deppe G
    Mt Sinai J Med; 1980; 47(4):394-7. PubMed ID: 6968031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer.
    Bagatell R; Khan O; Paine-Murrieta G; Taylor CW; Akinaga S; Whitesell L
    Clin Cancer Res; 2001 Jul; 7(7):2076-84. PubMed ID: 11448926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major molecular weight heterogeneity of estrogen receptor from breast cancer is not related to neoplasia.
    Maaroufi Y; Trivedi S; Leclercq G
    Cancer Biochem Biophys; 1995 Nov; 15(2):67-78. PubMed ID: 8590437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies against a component related to soluble estrogen receptor.
    Coffer AI; Lewis KM; Brockas AJ; King RJ
    Cancer Res; 1985 Aug; 45(8):3686-93. PubMed ID: 4016746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of human progesterone receptor by high performance hydrophobic interaction chromatography.
    Levy A; Boyle DM; van der Walt LA
    Biomed Chromatogr; 1991 Mar; 5(2):62-7. PubMed ID: 1868259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration.
    Murphy LJ; Murphy LC; Vrhovsek E; Sutherland RL; Lazarus L
    Cancer Res; 1984 May; 44(5):1963-8. PubMed ID: 6324992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid receptors in normal, hyperplastic and malignant human endometria.
    Vihko R; Jänne O; Kauppila A
    Ann Clin Res; 1980 Oct; 12(5):208-15. PubMed ID: 7015983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of estrogen receptor levels in endometrial cancer cells.
    Gurpide E; Blumenthal R; Fleming H
    Prog Clin Biol Res; 1984; 142():145-65. PubMed ID: 6709655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
    Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid receptors in prostate cancer tissues and cells: pathophysiology, problems in methodology, clinical value and controversial questions.
    Pavone-Macaluso M; Carruba G; Castagnetta L
    Arch Esp Urol; 1994 Mar; 47(2):189-201. PubMed ID: 8002681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
    Reiner GC; Katzenellenbogen BS
    Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of steroid hormone-dependency of tumours utilizing tissue sections. Survey of histochemical techniques and their application in surgical pathology.
    De Goeij TF; Bosman FT; Berns EM
    J Pathol; 1986 Jul; 149(3):163-72. PubMed ID: 3528443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormone receptors: clinical significance and problems in the treatment of breast cancer].
    Izuo M; Iino Y
    Gan No Rinsho; 1983 May; 29(6):637-43. PubMed ID: 6876433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression.
    Halmos G; Wittliff JL; Schally AV
    Cancer Res; 1995 Jan; 55(2):280-7. PubMed ID: 7812958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestins and breast cancer.
    Pasqualini JR
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.